PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

New Formulations and Indications

Phase Of Development

N/A

Sponsors and Collaborators

NINDS

Mechanism of Action

Mechanism Description

Prevention of seizures in infants with Tuberous Sclerosis

Populations Tested In

Tuberous Sclerosis Complex

Other Resources

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.